Estimating Cardiovascular and Limb Benefits of Combined Contemporary Risk Reduction Therapies in Patients with Symptomatic Peripheral Artery Disease: An Analysis of Randomized Controlled Trials

Mohamad A. Hussain,Tanujit Dey, Stuart R. Lipsitz,Deepak L. Bhatt,Subodh Verma,John W. Eikelboom,Marc P. Bonaca,Michael Belkin,C. Keith Ozaki,Mohammed Al-Omran

Circulation（2021）

引用 0|浏览0

暂无评分

摘要

Introduction: Individual randomized controlled trials (RCTs) have shown beneficial effects of low dose rivaroxaban and PCSK9 inhibition (PCSK9i) in addition to background aspirin and statin in pati...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要